These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38905272)

  • 1. Correction: CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.
    Mann L; Eyck PT; Wu C; Story M; Jenigiri S; Patel J; Honkanen I; O'Connor K; Tener J; Sambharia M; Fraer M; Noureddine L; Somers D; Nizar J; Antes L; Kuppachi S; Swee M; Kuo E; Huang CL; Jalal DI; Griffin BR
    PLoS One; 2024; 19(6):e0306216. PubMed ID: 38905272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.
    Mann L; Ten Eyck P; Wu C; Story M; Jenigiri S; Patel J; Honkanen I; O'Connor K; Tener J; Sambharia M; Fraer M; Nourredine L; Somers D; Nizar J; Antes L; Kuppachi S; Swee M; Kuo E; Huang CL; Jalal DI; Griffin BR
    PLoS One; 2023; 18(1):e0278550. PubMed ID: 36630406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto Y; Miki S; Shimada H; Tsujimoto H; Yasuda H; Kataoka Y; Fujii T
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013330. PubMed ID: 34519356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of two modalities of continuous renal replacement therapy.
    Duriseti P; Idrees N; Aldairem A; Jaber BL; Balakrishnan VS
    Hemodial Int; 2021 Apr; 25(2):173-179. PubMed ID: 33103356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D; Greenbaum LA
    Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.
    Wald R; Friedrich JO; Bagshaw SM; Burns KE; Garg AX; Hladunewich MA; House AA; Lapinsky S; Klein D; Pannu NI; Pope K; Richardson RM; Thorpe K; Adhikari NK
    Crit Care; 2012 Oct; 16(5):R205. PubMed ID: 23095370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.
    Kellum JA; Johnson JP; Kramer D; Palevsky P; Brady JJ; Pinsky MR
    Crit Care Med; 1998 Dec; 26(12):1995-2000. PubMed ID: 9875910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion.
    Cole L; Bellomo R; Davenport P; Tipping P; Ronco C
    Int J Artif Organs; 2004 May; 27(5):388-97. PubMed ID: 15202816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
    Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
    Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study.
    Bellomo R; Teede H; Boyce N
    Intensive Care Med; 1993; 19(6):329-32. PubMed ID: 8227722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1639-44. PubMed ID: 10817721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial.
    Weidhase L; Haussig E; Haussig S; Kaiser T; de Fallois J; Petros S
    PLoS One; 2019; 14(4):e0215823. PubMed ID: 31026303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF.
    Davies HT; Leslie G; Pereira SM; Webb SA
    Int J Artif Organs; 2008 Mar; 31(3):221-7. PubMed ID: 18373315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure.
    Valtonen M; Tiula E; Neuvonen PJ
    J Antimicrob Chemother; 1997 Nov; 40(5):695-700. PubMed ID: 9421318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting.
    Naka T; Egi M; Bellomo R; Cole L; French C; Botha J; Wan L; Fealy N; Baldwin I
    Anaesth Intensive Care; 2005 Oct; 33(5):601-8. PubMed ID: 16235478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.
    Brain M; Winson E; Roodenburg O; McNeil J
    BMC Nephrol; 2017 Feb; 18(1):69. PubMed ID: 28219324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.